These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3694178)

  • 1. Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved.
    Gould EA; Buckley A; Groeger BK; Cane PA; Doenhoff M
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3105-12. PubMed ID: 3694178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence.
    Gould EA; Buckley A
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1605-8. PubMed ID: 2543793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated early death in vivo after infection with yellow fever virus.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2539-42. PubMed ID: 3783130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment.
    Cane PA; Gould EA
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1241-6. PubMed ID: 3133449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
    Gould EA; Buckley A; Barrett AD; Cammack N
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():591-5. PubMed ID: 3950582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ; Foltzer M; Chapman S
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neurovirulence of different strains of yellow fever virus in mice.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():631-7. PubMed ID: 3958694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
    Buckley A; Gould EA
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurovirulence tests of three 17D yellow fever vaccine strains.
    Minor PD
    Biologicals; 2011 May; 39(3):167-70. PubMed ID: 21536454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody.
    Schlesinger JJ; Brandriss MW; Putnak JR; Walsh EE
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():593-9. PubMed ID: 2138210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo differentiation of strains of yellow fever virus in mice.
    Fitzgeorge R; Bradish CJ
    J Gen Virol; 1980 Jan; 46(1):1-13. PubMed ID: 6766176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain.
    Schlesinger JJ; Chapman S; Nestorowicz A; Rice CM; Ginocchio TE; Chambers TJ
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1277-85. PubMed ID: 8683217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
    Schlesinger JJ; Brandriss MW; Walsh EE
    J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of macrophages and antibody in resistance of mice against yellow fever virus.
    Zisman B; Wheelock EF; Allison AC
    J Immunol; 1971 Jul; 107(1):236-43. PubMed ID: 4326399
    [No Abstract]   [Full Text] [Related]  

  • 18. Basis of neurovirulence of avirulent rabies virus variant Av01 with stereotaxic brain inoculation in mice.
    Yang C; Jackson AC
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():895-900. PubMed ID: 1634878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
    Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
    J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.